Andrew John Matthew Clark
Président chez vasopharm GmbH
Fortune : 235 507 $ au 31/05/2024
Provenance du réseau au premier degré de Andrew John Matthew Clark
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Andrew John Matthew Clark via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| HENKEL AG & CO. KGAA | Household/Personal Care | Corporate Officer/Principal | |
CEVEC Pharmaceuticals GmbH
 CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| OCEAN WILSONS HOLDINGS LIMITED | Marine Shipping | Director/Board Member | |
Future Capital
 Future Capital Investment ManagersFinance Future Capital (Future Capital) is an independent venture capital firm which was founded in 1999 as the initiative of the Hessen State Government and Hoechst AG (now Sanofi-Aventis Group). The firm is headquartered in Frankfurt, Germany. | Investment Managers | Chief Executive Officer | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
| University of Bocconi | College/University | Undergraduate Degree | |
| University of Siegen | College/University | Doctorate Degree | |
| London Business School | College/University | Masters Business Admin | |
| Hannover Medical School | College/University | Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Masters Business Admin | |
| Heinrich-Heine-Universität Düsseldorf | College/University | Corporate Officer/Principal | |
Creathor Venture Management GmbH
 Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Investment Managers | Private Equity Investor | |
3i Private Equity
 3i Private Equity Investment ManagersFinance 3i Private Equity is a private equity firm, founded in 1945. The firm is headquartered in London, United Kingdom with additional offices around the world. | Investment Managers | Private Equity Investor | |
Algenex SL
 Algenex SL BiotechnologyHealth Technology Algenex SL develops and manufactures recombinant proteins. It specializes in the baculovirus vector-based innovative technologies to manufacture recombinant proteins used to produce vaccines, diagnostic reagents and therapeutic molecules. The company was founded by Jose Angel Martinez Escribano and Covadonga Alonso on January 19, 2005 and is headquartered in Pozuelo de Alarcon, Spain. | Biotechnology | Chief Executive Officer | |
Janssen-Cilag GmbH
 Janssen-Cilag GmbH Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen-Cilag GmbH is a German pharmaceutical company that focuses on innovative medical research and product development to create a future where disease is no longer a concern. The company is based in Neuss, Germany. The company's Janssen Trial Finder website is designed to inform patients and healthcare professionals about participating in a Janssen clinical trial and to search for clinical trials nearby. Janssen-Cilag was founded in 1959, and Iris Zemzoum has been the CEO of the company since 2012. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Julius-Maximilians-Universität Würzburg | College/University | Undergraduate Degree Corporate Officer/Principal | |
| HAML Consulting GmbH | Chief Investment Officer | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Peterhouse College Cambridge | College/University | Graduate Degree | |
| Ocean Wilsons (Investments) Ltd. | Director/Board Member | ||
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Director/Board Member | |
Fort Rock Capital Ltd.
 Fort Rock Capital Ltd. Financial ConglomeratesFinance Fort Rock Capital Ltd. provides investment services. The company is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
| Coller Capital Ltd. (Hong Kong) | Investment Managers | Corporate Officer/Principal | |
Medinet Midco I Ltd.
 Medinet Midco I Ltd. Medical/Nursing ServicesHealth Services Part of Medinet Topco Ltd., Medinet Midco I Ltd. is a provider of specialised clinical teams that deliver additional elective services to the NHS. The company is based in Sutton Coldfield, UK. Medinet Midco I offers urology and dermatology insourcing services, as well as fully managed specialised clinical teams. The British company was founded in 2016 and has been helping to reduce NHS waiting times for 15 years. | Medical/Nursing Services | Director/Board Member | |
| Medinet Bidco Ltd. | Miscellaneous | Director/Board Member | |
Cleon Capital Advisors SL
 Cleon Capital Advisors SL Investment ManagersFinance Cleon Capital Advisors SL (Cleon Capital Advisors) is a private equity firm founded in 2015 by Nicola Zambon. The firm is headquartered in Madrid, Spain with additional office in Milan. | Investment Managers | Consultant / Advisor | |
Hansa Capital GmbH
 Hansa Capital GmbH Financial ConglomeratesFinance Part of Hanseatic Asset Management LBG, Hansa Capital GmbH is a Swiss company that provides investment services. The company is based in Pfäffikon, Switzerland. | Financial Conglomerates | Chief Investment Officer | |
Greenhill & Co. Spain Ltd.
 Greenhill & Co. Spain Ltd. Investment ManagersFinance Part of Greenhill & Co., Inc., Greenhill & Co. Spain Ltd. is a Spanish company that provides financial advisory services. The company is based in Madrid, Spain. | Investment Managers | Private Equity Investor | |
Medinet Clinical Services Ltd.
 Medinet Clinical Services Ltd. Medical/Nursing ServicesHealth Services Part of Medinet Topco Ltd., Medinet Clinical Services Ltd. is a leading provider of specialised clinical teams delivering additional elective services to the NHS. The company is based in Sutton Coldfield, UK. The British company offers fully managed specialised clinical teams to help reduce NHS waiting times throughout the UK, including urology and general surgery insourcing. The company was founded in 2005 with the intention of easing the pressure on the NHS service, so that it can see and treat more patients. | Medical/Nursing Services | Director/Board Member | |
Medinet Midco II Ltd.
 Medinet Midco II Ltd. Financial ConglomeratesFinance Part of Medinet Topco Ltd., Medinet Midco II Ltd. functions as an investment holding British company. The company is based in Sutton Coldfield, UK and was founded in 2016. | Financial Conglomerates | Director/Board Member | |
| GAIN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| WILSON SONS S.A. | Other Transportation | Director/Board Member |
Statistiques
Internationale
| Allemagne | 13 |
| Royaume-Uni | 10 |
| Etats-Unis | 4 |
| Bermudes | 4 |
| Espagne | 4 |
Sectorielle
| Consumer Services | 11 |
| Finance | 10 |
| Health Technology | 6 |
| Transportation | 4 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 19 |
| Corporate Officer/Principal | 10 |
| Chief Executive Officer | 4 |
| Private Equity Investor | 4 |
| Doctorate Degree | 4 |
Relations les plus connectées
- Bourse
- Insiders
- Andrew John Matthew Clark
- Connexions Sociétés
